*ST Huicheng: Signs financial restructuring investment agreement with Zhenen Biotech and others

MetaMuskRat · 2026-04-03T07:08:31+00:00

*ST Huicheng has signed a restructuring financial investment agreement with Zhen'en Biological, Shanyuan Runhe, and Zhongjin Pucheng. Shanyuan Runhe and Zhongjin Pucheng will jointly acquire 114 million shares with an investment of 230 million yuan, at a share price of 2.01 yuan per share.

MetaMuskRat

2026-04-03 07:08:31

Abstract generation in progress

People’s Finance News, April 1 — *ST Huicheng (002168) issued an announcement on April 1. Recently, the company, together with Zien Biotechnology Co., Ltd. (hereinafter “Zien Biotech”), Chongqing Shanyuan Runhe Private Equity Investment Fund Partnership (Limited Partnership) (hereinafter “Shanyuan Runhe”), and CICC Pucheng Investment Co., Ltd. (hereinafter “CICC Pucheng”), signed the “Reorganization Financial Investor Agreement.” According to the agreement, Shanyuan Runhe and CICC Pucheng plan to acquire a total of 114 million shares of the company’s capital increase, and will pay a total reorganization investment amount of RMB 230 million, corresponding to an entry/share price of RMB 2.01 per share. Of this, Shanyuan Runhe is expected to contribute approximately RMB 206 million to obtain approximately 102 million shares, while CICC Pucheng is expected to contribute approximately RMB 24.1572 million to obtain 12 million shares.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes